News & Events

  • October 23, 2017

    Bloomberg published an article titled "2017 IPOs Are Larger and Faster" which analyzes the IPO market activity for the first three quarters of 2017.  In the Diversified sector, Ellenoff Grossman & Schole led with 11 IPOs that raised a total of $2.10 billion, but Weil Gotshal & Manges participated in six IPOs that totaled $3.55 billion. Venable led the Financial sector with seven IPOs that raised a total of $2.76 billion. The Industrial sector was dominated by Latham & Watkins and Simpson Thacher & Bartlett, while the Technology sector was led by Wilson Sonsini Goodrich & Rosati.

    Click here to read the full article.

  • October 20, 2017

    Connekt Media Inc. announced the closing of their bridge loan in the amount of $2,000,000.  EG&S acted as counsel to the Investor.

  • October 17, 2017

    CASI Pharmaceuticals Inc. announced the closing of their Registered Direct offerings in the amount of $23,855,595.  EG&S acted as counsel to the Placement Agent.

  • October 13, 2017

    Intellipharmaceutics International Inc. announced the closing of their Registered Direct offering in the amount of $4,000,000.  EG&S acted as counsel to the Placement Agent.

     

  • October 12, 2017

    Cellectar Biosciences Inc. announced the closing of their Registered Direct offering in the amount of $7,766,164.  EG&S acted as counsel to the Placement Agent.

  • October 11, 2017

    Rimini Street, Inc., a global provider of enterprise software products and services, announced the closing of its merger with special purpose acquisition company GP Investments Acquisition Corp. The combined company will retain the Rimini Street, Inc. name and will trade on Nasdaq as “RMNI.”  The transaction was valued at $50,000,000. Cowen served as financial and capital markets advisor to Rimini Street, and EG&S acted as counsel to Cowen.

  • October 04, 2017

    Jaguar Health, Inc. announced the closing of its public underwritten offering of common stock in the amount of $4,250,000.   EG&S acted as counsel to the underwriter, Maxim Group, LLC.

  • October 04, 2017

    Aethlon Medical, Inc. announced the closing of their Registered Direct offering in the amount of $6,000,000.  EG&S acted as counsel to the Placement Agent.

  • October 03, 2017

    The Deal's exclusive League Table ranking tracks PIPEs that raise at least $1 million between January 1 and September 15, 2017.  Ellenoff Grossman & Schole LLP was the top-ranked agent legal counsel with eight placements advised and tied for second, with four placements advised for investor legal counsel.

    Click here to read the full report.

  • October 02, 2017

    Nacuity Pharmaceuticals, Inc. announced the closing of their private placement of preferred stock and warrants in the amount of $9,422,000 over three closings.  EG&S acted as counsel to Maxim Group LLC.

  • October 02, 2017

    Rosetta Genomics announced the closing of their PIPE offering in the amount of $2,000,000.  EG&S acted as counsel to the Investor.

  • September 25, 2017

    China National Heavy Duty Truck Group Co. Ltd. announced that it has acquired 9.9% of UQM Technologies, Inc. (NYSE American: UQM) and has agreed to acquire an additional 24.1% of UQM subject to approval by the U.S. Committee on Foreign Investment in the United States (“CFIUS”). EGS is acting as counsel to CNHTC.

  • September 22, 2017

    Inspyr Therapeutics Inc. announced the closing of their Registered Direct offering in the amount of $1,750,000.  EG&S acted as counsel to the Placement Agent.

  • September 22, 2017

    DelMar Pharmaceuticals announced the closing of their Registered Direct offering in the amount of $10,000,000.  EG&S acted as counsel to the Placement Agent.

  • September 20, 2017

    Draper Oakwood Technology Acquisition, Inc. announced the closing of its initial public offering in the amount of $50,000,000.  EG&S acted as counsel to Draper Oakwood.

  • September 19, 2017

    Douglas Ellenoff, Stuart Neuhauser and Matthew Gray; members of the Firm, were invited by Strafford to participate on a Webinar titled:Special Purpose Acquisition Companies: Structuring IPOS and Facilitating Future Mergers and Acquisitions.  The panel discussed the disclosure and operational requirements particular to SPACs, the timing and valuation parameters relating to SPAC target acquisitions and issues that may arise in a SPAC’s initial business combination. The panel also discussed the typical pricing of SPAC securities and trust accounts.

    Click here to view the Strafford presentation.

  • September 19, 2017

    Rennova Health, Inc. announced the closing of their PIPE offering in the amount of $6,412,136.  EG&S acted as counsel to the Investor.

  • September 18, 2017

    STRATA Skin Science Inc. announced the closing of their Registered Direct offering in the amount of $40,652,594.  EG&S acted as counsel to the Lead Investor.

  • September 15, 2017

    Moleculin Biotech, Inc. announced the closing of their At the Market offering.  EG&S acted as counsel to the Placement Agent.

  • September 12, 2017

    Inspyr Therapeutics Inc. announced the closing of their PIPE & Exchange offering in the amounts of $320,000.00 & $2,504,812. EG&S acted as counsel to the Investor.

  • August 28, 2017

    Cel-Sci Corporation announced the closing of their Registered Direct offering in the amount of $3,500,000.  EG&S acted as counsel to the Placement Agent.

  • August 22, 2017

    Lakeland Industries, Inc. announced the closing of their Underwritten offering in the amount of $10,005,000.  EG&S acted as counsel to the Underwriter.

  • August 21, 2017

    Avista Healthcare Public Acquisition Corp. announced that it has entered into a definitive merger agreement with Envigo International Holdings, Inc., a leading early stage non-clinical contract research organization offering a diverse set of non-clinical discovery and safety assessment services as well as laboratory animal science tools.  EG&S acted as special SPAC counsel to Envigo.

  • August 18, 2017

    EG&S acted as counsel to Movie Pass, Inc. which recently announced that it has entered into an agreement with Helios and Matheson Analytics Inc. pursuant to which Helios will buy 51% of the outstanding stock of MoviePass. MoviePass, a movie subscription technology company established in 2011, has been led by Netflix co-founder and former Redbox president Mitch Lowe as CEO since June 2016, along with MoviePass co-founder Stacy Spikes. The transaction will be valued at up to $27,000,000.

  • August 18, 2017

    I-AM Capital Acquisition Company announced the closing of its initial public offering in the amount of $50,000,000.  EGS acted as counsel to I-Am.